Company profile: QuantuMDx
1.1 - Company Overview
Company description
- Provider of handheld and portable low-cost diagnostic and genomic sequencing platforms, including the Q-POC rapid multiplex PCR point-of-care system; assays for SARS-CoV-2, Flu A/B, RSV; a research-use TB host immune response assay; a saliva-based SARS-CoV-2 RT-PCR test; CAPTURE-XT lab-on-chip pathogen concentration; and microarray technologies for high-throughput genetic marker screening.
Products and services
- Q-POC™ Platform: A battery-operated rapid multiplex PCR system enabling portable point-of-care diagnostics with approximately 30-minute turnaround, engineered for on-site testing workflows
- Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay: A rapid PCR test that detects and distinguishes SARS-CoV-2, Flu A, Flu B, and RSV infections, delivering 35-minute results on a single run
- CAPTURE-XT®: A microfluidic lab-on-chip pathogen concentration system using dielectrophoresis to capture and concentrate Mycobacterium tuberculosis cells from sputum samples for downstream analysis.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QuantuMDx
C2i Genomics
HQ: United States
Website
- Description: Provider of cloud-based cancer diagnostic services for pharmaceutical and diagnostic organizations, offering the C2-Intelligence Platform that leverages whole-genome sequencing and AI to detect minimal residual disease, low-input liquid biopsy, and services for MRD-guided adjuvant treatment, organ preservation decisions, treatment response monitoring, and early recurrence detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full C2i Genomics company profile →
Aura Biosciences
HQ: United States
Website
- Description: Provider of virus-like drug conjugates (VDCs) using virus-like particles to target solid tumors by delivering cytotoxic drugs or nucleic acids. Develops Belzupacap Sarotalocan (Bel-sar) for first-line treatment of early-stage choroidal melanoma and other ocular oncology indications, with potential in choroidal metastasis, aiming to preserve vision and prevent metastatic disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aura Biosciences company profile →
InVivo Biotech Services
HQ: Germany
Website
- Description: Provider of contract manufacturing services for development and production of monoclonal antibodies and recombinant proteins. Offerings include antibody production from hybridomas (small to large scale), recombinant protein expression in bacterial and mammalian systems, non-GMP cell line development, research antibodies produced in HEK under serum-free conditions, and SARS‑CoV‑2 antigens and antibodies for immunoassays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InVivo Biotech Services company profile →
AutoGenomics
HQ: United States
Website
- Description: Provider of automated microarray-based multiplex molecular diagnostic platforms and genetic testing tools, including INFINITI System, INFINITI PLUS Analyzer, INFINITI High Throughput System, proprietary BioFilmChip microarrays, and assays such as AvertD for opioid use disorder risk and Factor II-V Leiden for thrombophilia, for disease signature assessment in women's health, cancer and personalized medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AutoGenomics company profile →
Medicinal Genomics
HQ: The Netherlands
Website
- Description: Provider of genomics-driven testing and breeding solutions for medical cannabis and hemp, including the PathoSEEK qPCR-based microbial safety testing platform and detection assays for flower, extracts, and infused products; SenSATIVAx DNA purification kits; FemINDICAtor qPCR plant sex testing; and genomic services to identify markers for desirable traits and accelerate breeding programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicinal Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QuantuMDx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QuantuMDx
2.2 - Growth funds investing in similar companies to QuantuMDx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QuantuMDx
4.2 - Public trading comparable groups for QuantuMDx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →